Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Cancer Cell International|April 4, 2023
A novel NHEJ gene signature based model for risk stratification and prognosis prediction in hepatocellular carcinomaZhu Lin, Zhenkun Huang, Yunxing Shi, et al.Journal of Materials Chemistry. B|June 6, 2025
Correction: Virus-like particles nanoreactors: from catalysis towards bio-applicationsYuqing Su, Beibei Liu, Zhenkun Huang, et al.International Immunopharmacology|July 19, 2024
Atezolizumab and bevacizumab plus transarterial chemoembolization and hepatic arterial infusion chemotherapy for patients with high tumor burden unresectable hepatocellular carcinoma: A multi-center cohort studyZhenkun Huang, Tiejun Chen, Wenbin Li, et al.Clinical and Experimental Medicine|June 28, 2024
PD-L1 inhibitor versus PD-1 inhibitor plus bevacizumab with transvascular intervention in unresectable hepatocellular carcinomaZhenkun Huang, Tiejun Chen, Wenbin Li, et al.Journal of Experimental & Clinical Cancer Research : CR|July 25, 2024
m6A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinomaZhu Lin, Zhenkun Huang, Jiliang Qiu, et al.Journal of Cancer Research and Clinical Oncology|August 26, 2023
Repeat hepatectomy versus percutaneous ablation for recurrent hepatocellular carcinoma: emphasis on the impact of early or late recurrenceChenwei Wang, Kai Li, Zhenkun Huang, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 12, 2024
Biodegradable Ruthenium-Rhenium Complexes Containing Nanoamplifiers: Triggering ROS-Induced CO Release for Synergistic Cancer TreatmentAijie Liu, Zhenkun Huang, Xiangfu Du, et al.Cell Death Discovery|November 28, 2023
METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibitionFangfang Bi, Yuxiong Qiu, Zongfeng Wu, et al.Med (New York, N.Y.)|May 7, 2026
Sintilimab and lenvatinib plus hepatic arterial infusion chemotherapy and embolization as conversion therapy for uHCC: A phase 2 trialJiliang Qiu, Zhenkun Huang, Wei He, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 15, 2024
Prognosis predictors of hepatocellular carcinoma after hepatectomy following conversion therapyShaoru Liu, Zongfeng Wu, Chenwei Wang, et al.Pageof 4